𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence

✍ Scribed by Mohammad Taghi Joghataie; Mehrdad Roghani; Fereidoun Negahdar; Leila Hashemi

Book ID
116819999
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
237 KB
Volume
10
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroprotective effect of riluzole in a
Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence
✍ Maria C. Obinu; Michel Reibaud; Véronique Blanchard; Saliha Moussaoui; Assunta I 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

## Abstract Our study aimed to determine whether riluzole, which has shown efficacy as a disease‐modifying agent in amyotrophic lateral sclerosis (ALS), is neuroprotective in a marmoset model of Parkinson's disease (PD). Reduction of energy demand by riluzole could be a rational neuroprotective str

Hexokinase II gene transfer protects aga
Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease
✍ Juan Carlos Corona; Alfredo Gimenez-Cassina; Filip Lim; Javier Díaz-Nido 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

## Abstract A typical feature of Parkinson's disease is the progressive loss of dopaminergic neurons in the substantia nigra, in which inhibition of mitochondrial complex I activity may play an important role. Rotenone or 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) inhibit the mitochondrial